CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $300,000 worth of Ethereum (ETH), increasing its total investment in ETH to $1.8 million.

JPMorgan raised Argan to overweight from neutral.

Amid mixed signals about iPhone 17 sales, Apple stock has been an underperformer. It could limp along until next spring, one analyst says.

CommScope's 192.2% surge highlights strong product demand and strategic partnerships, though rising competition and trade risks temper the outlook.

Broadcom (AVGO) surged after penning a massive deal with OpenAI that includes building 10 gigawatts of custom A.I. accelerators to enhance OpenAI's infrastructure.

Get Forbes Breaking News Text Alerts: We're launching text message alerts so you'll always know the biggest stories shaping the day's headlines. Text “Alerts” to (201) 335-0739 or sign up here: joinsubtext.com/forbes.

Record streaming engagement, new partnerships, and original programming mark a defining phase for the SEGG Media-owned platform Record streaming engagement, new partnerships, and original programming mark a defining phase for the SEGG Media-owned platform

Demand for precious metals stays strong at the start of the week.

Once the darling of the plant-based boom, Beyond Meat Inc (NASDAQ:BYND) has gone from market disruptor to market casualty. At its 2019 peak, the company was valued at over $13 billion.

ORINDA, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) announced the launch of a tender offer to purchase up to 150,000 Class S shares of Starwood Real Estate Income Trust, Inc. (“Starwood”) for $16.25 per share, an approximate 22% discount to Starwood's estimated net asset value of $20.76 as of August 31, 2025.

Shares of Angi are down nearly 25% in the past month despite investors initially reacting favorably to Q2 results. Management has intentionally shed lower quality revenue, helping maintain earnings this year, despite considerably lower overall revenue. I see a return to mid single growth next year, along with margin expansion.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Reddit, Inc. ("Reddit" or the "Company") (NYSE: RDDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of James Hardie Industries plc ("James Hardie" or the "Company") (NYSE: JHX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Matrix Service Company ("Matrix" or the "Company") (NASDAQ: MTRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ: MLTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortress Biotech Inc. ("Fortress" or the "Company") (NASDAQ: FBIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Freeport-McMoran Inc. ("Freeport" or the "Company") (NYSE: FCX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.